Literature DB >> 8598618

Incidence of and treatment for ductal carcinoma in situ of the breast.

V L Ernster1, J Barclay, K Kerlikowske, D Grady, C Henderson.   

Abstract

OBJECTIVE: To describe trends in incidence and treatment for ductal carcinoma in situ (DCIS) of the breast in the United States between 1973 and 1992 and to estimate total numbers of in situ cases diagnosed and numbers treated by mastectomy since 1983, when screening mammography for breast cancer began to become widespread.
DESIGN: Analysis of population-based breast cancer incidence data collected by the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program since 1973 and treatment data collected by the SEER program since 1983. STUDY POPULATION: All women in the geographic areas af the United States included in the SEER program. MAIN OUTCOME MEASURES: Annual age-adjusted and age-specific incidence rates for DCIS; time trends in distribution of cases by type of treatment; percentage of cases treated by mastectomy by geographic area; and estimated numbers for the entire United States of DCIS cases, mastectomies for DCIS, and cases attributable to mammography.
RESULTS: There was a marked increase in DCIS incidence beginning in the early 1980s. Average annual increases in rates between 1973 and 1983 and between 1983 and 1992 changed from 0.3% to 12.0% among women aged 30 to 39 years, from 0.4% to 17.4% among women aged 40 to 49, and from 5.2% to 18.1% among women aged 50 years or older. The total estimated number of DCIS cases in the United States in 1992 (23,368) was 200% higher than expected based on 1983 rates and trends between 1973 and 1983. Between 1983 and 1992, there was a marked decline in the proportion of DCIS cases treated by mastectomy (from 71% to 43.8%) and an increase in those treated by lumpectomy (from 25.6% to 53.3%). In 1992, 23.3% of cases were treated by lumpectomy and radiation, 30.2% by lumpectomy alone, and 2.6% with no surgery. Treatment patterns varied substantially by geographic area, with 57.7% of cases in New Mexico treated by mastectomy in 1992 compared with 28.8% in Connecticut. Despite the decline in the proportion of cases treated by mastectomy, the increased DCIS incidence rates resulted in an increase in the absolute number of cases treated by mastectomy until 1990 (n=10,657); in 1992, there were an estimated 10,242 DCIS cases treated by mastectomy.
CONCLUSIONS: Incidence rates of DCIS of the breast have increased dramatically since 1983. This increase correlates with the widespread adoption of modern mammographic screening. While early detection of invasive breast cancer is beneficial, the value of DCIS detection is currently unknown. There is cause for concern about the large number of DCIS cases that are being diagnosed as a consequence of screening mammography, most of which are treated by some form of surgery. In addition, the proportion of cases treated by mastectomy may be inappropriately high, particularly in some areas of the United States.

Entities:  

Mesh:

Year:  1996        PMID: 8598618

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  96 in total

1.  Mammography in New Hampshire: characteristics of the women and the exams they receive.

Authors:  P A Carney; M E Goodrich; D M O'Mahony; A N Tosteson; M S Eliassen; S P Poplack; S Birnbaum; B G Harwood; K A Burgess; B T Berube; W S Wells; J P Ball; M M Stevens
Journal:  J Community Health       Date:  2000-06

Review 2.  The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.

Authors:  J F Simpson; D L Page
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Is mastectomy overused? A call for an expanded research agenda.

Authors:  Paula V Lantz; Judith K Zemencuk; Steven J Katz
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

Review 4.  Clinical practice. Mammographic screening for breast cancer.

Authors:  Suzanne W Fletcher; Joann G Elmore
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 5.  Imaging for the diagnosis and management of ductal carcinoma in situ.

Authors:  Carl J D'Orsi
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 6.  Mode of detection and secular time for ductal carcinoma in situ.

Authors:  Etta D Pisano
Journal:  J Natl Cancer Inst Monogr       Date:  2010

7.  Evaluating new screening tests for breast cancer.

Authors:  Les Irwig; Nehmat Houssami; Bruce Armstrong; Paul Glasziou
Journal:  BMJ       Date:  2006-03-25

Review 8.  Screening for breast cancer.

Authors:  Joann G Elmore; Katrina Armstrong; Constance D Lehman; Suzanne W Fletcher
Journal:  JAMA       Date:  2005-03-09       Impact factor: 56.272

9.  Clinical experience of patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery plus radiotherapy: a preliminary report.

Authors:  Ji-Young Jang; Mi-Ryeong Ryu; Sung-Whan Kim; Chul-Seung Kay; Yeon-Sil Kim; Yoon-Kyeong Oh; Hyung-Chul Kwon; Sei-Chul Yoon; Woo-Chan Park; Byung-Joo Song; Se-Jeong Oh; Sang-Seol Jung; Jong-Man Won; Seung-Nam Kim; Su-Mi Chung
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

10.  Socioeconomic disparities in the decline in invasive breast cancer incidence.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Elizabeth S Burnside
Journal:  Breast Cancer Res Treat       Date:  2010-01-20       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.